Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0131
0.00 (0.00%)
At close: Sep 1, 2026
Vincerx Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -22.65 | -30.07 | -40.16 | -62.98 | -39.31 | -16.62 |
Depreciation & Amortization | 0.83 | 1.09 | 0.92 | 0.94 | 0.34 | - |
Other Amortization | - | - | - | - | - | 0.02 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 5 |
Loss (Gain) From Sale of Investments | -0.21 | -0.21 | -0.63 | -0.29 | - | - |
Stock-Based Compensation | 3.38 | 3.47 | 3.56 | 10.06 | 23.31 | 4.38 |
Other Operating Activities | -3.7 | -0.23 | 0.05 | -6.3 | -23.36 | 5.9 |
Change in Accounts Payable | -0.05 | -0.47 | -1.57 | 1.05 | 1.53 | 0.46 |
Change in Other Net Operating Assets | -0.45 | 0.29 | -2.62 | -2.07 | 4.08 | -1.42 |
Operating Cash Flow | -22.84 | -26.13 | -40.45 | -59.6 | -33.4 | -2.28 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | - | - | - | - | -0.26 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -5 | - |
Investment in Securities | 0.21 | 0.21 | 41.5 | -40.58 | - | - |
Investing Cash Flow | 0.21 | 0.21 | 41.5 | -40.58 | -5.26 | - |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Short-Term Debt Issued | - | - | - | - | - | 0.3 |
Total Debt Issued | - | - | - | - | - | 0.3 |
Short-Term Debt Repaid | - | - | - | - | - | -0.3 |
Total Debt Repaid | - | - | - | - | - | -0.3 |
Issuance of Common Stock | 21.84 | 17.99 | 0.11 | 0.28 | 88.45 | - |
Other Financing Activities | - | - | - | - | - | 64.07 |
Financing Cash Flow | 21.84 | 17.99 | 0.11 | 0.28 | 88.45 | 64.07 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 0.11 | 0.14 | -0.04 | 0.07 | -0.02 | - |
Net Cash Flow | -0.67 | -7.79 | 1.12 | -99.83 | 49.77 | 61.79 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -22.84 | -26.13 | -40.45 | -59.6 | -33.66 | -2.28 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -9.06 | -13.77 | -37.98 | -56.69 | -39.19 | -8.68 |
Levered Free Cash Flow | -15.87 | -12.24 | -24.29 | -40.13 | -44.46 | - |
Unlevered Free Cash Flow | -15.87 | -12.24 | -24.29 | -40.13 | -44.46 | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | - | - | - | - | 0.03 | 0.03 |
Change in Working Capital | -0.49 | -0.18 | -4.19 | -1.02 | 5.61 | -0.96 |